ES2089182T3 - Solubilizacion y purificacion del receptor del peptido liberador de gastrina. - Google Patents

Solubilizacion y purificacion del receptor del peptido liberador de gastrina.

Info

Publication number
ES2089182T3
ES2089182T3 ES91900632T ES91900632T ES2089182T3 ES 2089182 T3 ES2089182 T3 ES 2089182T3 ES 91900632 T ES91900632 T ES 91900632T ES 91900632 T ES91900632 T ES 91900632T ES 2089182 T3 ES2089182 T3 ES 2089182T3
Authority
ES
Spain
Prior art keywords
gastrine
solubilization
purification
releasing peptide
peptide receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900632T
Other languages
English (en)
Inventor
Richard I Feldman
James M Wu
Elaina Mann
Anne Larocca
James C Jenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berlex Laboratories Inc
Original Assignee
Berlex Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/426,150 external-priority patent/US5215963A/en
Application filed by Berlex Laboratories Inc filed Critical Berlex Laboratories Inc
Application granted granted Critical
Publication of ES2089182T3 publication Critical patent/ES2089182T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/286—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5758—Gastrin releasing peptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

EL RECEPTOR PEPTIDO LIBERADOR DE LA GASTRINA SE SOLUBILIZA Y PURIFICA DE FORMA ACTIVA. SE PRESENTAN LA SECUENCIA AMINOACIDO Y EL ADN QUE CODIFICA EL RECEPTOR.
ES91900632T 1989-10-24 1990-10-23 Solubilizacion y purificacion del receptor del peptido liberador de gastrina. Expired - Lifetime ES2089182T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/426,150 US5215963A (en) 1989-10-24 1989-10-24 Solubilization and purification of the active gastrin releasing peptide receptor
US53365990A 1990-06-05 1990-06-05

Publications (1)

Publication Number Publication Date
ES2089182T3 true ES2089182T3 (es) 1996-10-01

Family

ID=27026933

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900632T Expired - Lifetime ES2089182T3 (es) 1989-10-24 1990-10-23 Solubilizacion y purificacion del receptor del peptido liberador de gastrina.

Country Status (8)

Country Link
EP (2) EP0524173B1 (es)
JP (2) JPH05506981A (es)
AT (1) ATE139565T1 (es)
AU (2) AU640480B2 (es)
CA (2) CA2067766A1 (es)
DE (1) DE69027542T2 (es)
ES (1) ES2089182T3 (es)
WO (2) WO1991006646A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2067766A1 (en) * 1989-10-24 1991-04-25 Richard I. Feldman Gastrin releasing peptide receptor
CA2105306A1 (en) * 1991-03-15 1992-09-16 James F. Battey, Jr. Receptors for bombesin-like peptides
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
US20050019325A1 (en) 1996-01-08 2005-01-27 Carter Paul J. WSX receptor agonist antibodies
EP0977579B1 (en) * 1997-04-22 2009-03-11 Curator Of The University Of Missouri Gastrin receptor-avid peptide conjugates
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
WO2005109001A2 (en) * 2004-05-12 2005-11-17 Galapagos N.V. Methods, compositions and compound assays for inhibiting amyloid-beta protein production

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2067766A1 (en) * 1989-10-24 1991-04-25 Richard I. Feldman Gastrin releasing peptide receptor
AU1707892A (en) * 1991-05-22 1993-03-11 Ludwig Institute For Cancer Research Gastrin-binding protein

Also Published As

Publication number Publication date
DE69027542T2 (de) 1996-12-12
WO1991006646A1 (en) 1991-05-16
AU640480B2 (en) 1993-08-26
DE69027542D1 (de) 1996-07-25
AU641210B2 (en) 1993-09-16
EP0524173A1 (en) 1993-01-27
AU7039491A (en) 1991-05-31
JPH05506981A (ja) 1993-10-14
ATE139565T1 (de) 1996-07-15
CA2067766A1 (en) 1991-04-25
WO1991006647A1 (en) 1991-05-16
AU7740691A (en) 1991-05-31
JPH05505097A (ja) 1993-08-05
CA2069965A1 (en) 1991-04-25
EP0497866A1 (en) 1992-08-12
EP0524173B1 (en) 1996-06-19

Similar Documents

Publication Publication Date Title
DE3785388D1 (de) Antivirale peptide und mittel zur behandlung von herpes.
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
DE69133593D1 (de) Menschliches CNP-Gen und Vorläuferprotein
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
DK6893D0 (da) Peptid
SE8803847A0 (sv) Neuromodulerande peptid
DK499886A (da) Peptid
ES2089182T3 (es) Solubilizacion y purificacion del receptor del peptido liberador de gastrina.
DE3685651D1 (de) Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
DK403384D0 (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
DE3778550D1 (de) Fieber- und entzuendungshemmende peptide.
IE852596L (en) Peptides active on the cns
KR960702754A (ko) 생리적으로 활성인 펩티드를 함유하는 질내 투여 제제(vaginal preparation containing physiologically active peptide)
IL83347A0 (en) Recombinant htlv-iii proteins and their use
DE68906066D1 (de) Peptid und dessen salze und antiallergische peptidmittel, welche diese peptide enthalten.
NO177858C (no) Peptid
IT8748235A0 (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti
DK1612555T3 (da) Kryptiske peptider til anvendelse til at inducere immunologisk tolerance
DE3869939D1 (de) Biologisch wirksame peptide.
DE3780388D1 (de) Fsh-stimulierendes peptid.
DE3782199D1 (de) Biologisch aktive peptide tan-866.
DK136088D0 (da) Peptid
ATE81531T1 (de) Biologisch aktive peptide tan-866.
DE69019581T2 (de) Polypeptid und dieses enthaltende antibaktierelle Präparate.
ATE88189T1 (de) Antivirale peptide und mittel zur behandlung von herpes.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 524173

Country of ref document: ES

FG2A Definitive protection

Ref document number: 524173

Country of ref document: ES